Si-Ping Han

Title: The Innovative Contributions of Si-Ping Han

Introduction

Si-Ping Han is a notable inventor based in Duarte, California, recognized for his significant contributions to the field of biotechnology. With a total of four patents to his name, Han has focused on developing innovative solutions for medical challenges, particularly in the treatment of cardiac conditions.

Latest Patents

Among his latest patents is the invention titled "Conditional-siRNAS and uses thereof in treating cardiac hypertrophy." This patent discloses conditional siRNAs that can be activated by pro-hypertrophic RNA sequences, providing a novel approach to treating cardiac hypertrophy by targeting calcineurin or HDAC2. Another significant patent is "Meta-stable oligonucleotides junctions for delivery of therapeutics." This invention describes multi-way oligonucleotide junctions designed for delivering one or more cargo molecules to biological targets. These junctions are stable outside the cell and can easily dissociate within the cell to release the therapeutic cargo, enhancing targeted delivery.

Career Highlights

Si-Ping Han has worked with prestigious institutions such as the California Institute of Technology and City of Hope. His work at these organizations has allowed him to collaborate with leading experts in the field, further advancing his research and innovations.

Collaborations

Some of his notable coworkers include William A. Goddard III and Lisa Scherer, who have contributed to his research endeavors and the development of his patented technologies.

Conclusion

Si-Ping Han's innovative work in biotechnology, particularly in the development of therapeutic delivery systems and treatments for cardiac hypertrophy, showcases his commitment to advancing medical science. His contributions continue to have a significant impact on the field.